Pharmaceutical Science and Drug Manufacturing and Development

Francois-Xavier Frapaise, M.D has over 40 years of international drug development, regulatory ,strategic planning and marketing experience at major pharmaceutical companies including Sanofi, Bayer, Boehringer, Merck and Abbott; he has hold multiple C-level positions (CSO,CMO,CEO) in different Pharmacos in the US and Europe. Until recently ,he was heading Clinical Development, Medical Affairs and Pharmacovigilance at Merck KGaA Biosimilars Division; he has extensive experience of biosimilars development acquired at Boehringer-Ingelheim and Pfenex); his recent focus of interest is Blockchain Technology application in Pharma. He has been the CSO and SVP of Optimer, has served as the CEO of Asphelia Pharmaceuticals, Inc. VP R&D and Corporate Officer of TAP , CMO of Ocera Therapeutics, VP of Scientific Affairs at Abbott International , Head of Medical Affairs at Bayer Europe, Medical Director at Bayer France, VP of R&D at Delagrange, Head of Anti-thrombotics Strategic Marketing at Sanofi, Medical Director at Choay. Dr. Frapaise holds an M.D. degree from Faculté de Médecine Paris and is a INSEAD alumni. Dr. Frapaise holds an academic position at the Thrombosis Research Center (Loyola Medical Center in Maywood (IL). He is part of Boston-based Trestle Compliance leadership team. He now runs a consulting business, based in Paris.

Dr. Frapaise holds an M.D. degree from Faculté de Médecine Paris and is a INSEAD alumni. Dr. Frapaise holds an academic position at the Thrombosis Research Center (Loyola Medical Center in Maywood (IL). He is part of Boston-based Trestle Compliance leadership team.Dr. Frapaise holds an M.D. degree from Faculté de Médecine Paris and is a INSEAD alumni. Dr. Frapaise holds an academic position at the Thrombosis Research Center (Loyola Medical Center in Maywood (IL). He is part of Boston-based Trestle Compliance leadership team.

Ng Yi Ling studying final year B.Pharm ytudent at International Medical University, Malaysia.She acted as a IMU Student Ambassadors from 2016-2017.And also worked as a Relationship Manager of Malaysia World Health Assembly (MyWHA) 2017

Pharmacy

Ling Peng is a leading expert in developing functional dendrimer nanosystems for drug delivery in biomedical applications.Dr. Ling Peng is a research director at the French National Scientific Research Center (CNRS). She carried her undergraduate study in chemistry at Nanjing University in China, then joined the group of Professor Albert Eschenmoser at Swiss Federal Institute of Polytechnic in Zurich in 1987 for her Ph.D program. After she completed her Ph.D thesis on the synthesis of modified DNA oligonucleotides in 1993, she spent three years as a postdoctoral research fellow in the group of Prof. Maurice Goeldner at Louis Pasteur University in Strasbourg in France, where she developed various photosensitive probes to investigate the functions of cholinesterases and biomembranes.She has successfully established bio-inspired structurally flexible and self-assembling dendrimer nanosystems for drug and nucleic acid delivery. One of the dendrimers developed by her team has been scheduled in clinical trials. Dr Peng has coordinated and participated in different European projects and actively involved in several European CAOST Actions.er research team has been labelled by La Ligue contre Le Cancer in France for the period of 2016-2020, and she was awarded for the Prize of Dr and Mrs Henri Labbé by the French Academy of Sciences in 2017.

Functional Dendrimers for Nucleic Acid Delivery,Triazole Nucleoside Chemistry for Drug Discovery, Molecular Probes and Chemical Biology.

Dr. Md. Faiyazuddin has over 11 years of experience as a teacher & researcher with expertise in Pharmaceutical Nanotechnology & Clinical Nanomedicine. He is currently Principal of the Bihar College of Pharmacy at Magadh University, Patna, India. He is an associate member of Institute of Nanotechnology, Sterling University, Scotland, British Society of Nanomedicine, University of Liverpool, International Society of Aerosol in Medicine and American Lung Association, Chicago.

Nano Dry powders for Asthma Therapy, Nanoconjugates of botanicals in hepatoprotection, Chemopreventive nanodelivery approaches for Anticancer agents, Lipid Nanoparticles for Skin Delivery of Botanicals, Ocular Nanopharmaceutics

Dr Allen Lai received his Ph.D. and MPA, from Lee Kuan Yew School of Public Policy, National University of Singapore, M.Sc. (Preventive Medicine) from National Taiwan University and M.D. from Chung Shan Medical Dental University, Taiwan. He was the principal consultant at IMS Health Asia, a leading global information and technology services company in the healthcare industry, and the director of Institute of Health Economics & Management and the academic director of MSc Management of Health Industries in ESSEC Business School. He was also the attending physician in National Taiwan University Hospital and Taipei City Hospital. He has authored more than 40 articles in peer-reviewed journals. He holds several high key profile roles as President of ISPOR, Singapore Regional Chapter and concurrently the Consultant in Urology, and Advisor for Ministry of Health and Social Welfare, Taiwan.

Urology.

Nabeel Martani was born in Iraq on 18th April 1973 Bachelor of Dental and Oral Surgery (B.D.S) from Dentistry / Mosul University.Master of Science in Conservative Dentistry (M.Sc.)from Dentistry / Salahaddin University.Doctor of Philosophy in Fixed and Removable Prosthodontics (PH.D.)from Dentistry / Beirut Arab University(lebanon)

Oral Rehabilitation Science,Conservative Dentistry

Lobna Karoui received the Master Degree on “intelligent systems” from the University Paris Dauphine in 2004. Then, she started her PhD research in the University Paris-Sud Orsay and in the Electrical Higher School in Paris, France. She obtained her PhD in 2008. Based on the Information technology background and Artificial Intelligence Research, she works on applied research to help companies on developing Artificial Intelligence projects for their business and customers such as semantic analysis in different functional domains, knowledge discovery, disruptive services, intelligent agents.

Artificial Intelligence domain, Machine Learning, Cognitive Science and Semantic Web

Illinois Institute of Technology (IIT), Chicago, Illinois, U.S.A. Department of Chemical Engineering (September 1987 ~ December 1992) Ph.D. in Chemical Engineering, December 1992 and Seoul National University, Seoul, Republic of Korea Department of Chemical Engineering (March 1981 ~ February 1985) B.S. in Chemical Engineering, February 1985

• Nanobiotechnology • Nanomedicine & Biosensor/Biochip • Protein Engineering